Baricitinib in combination with remdesivir reduced time to recovery in hospitalized patients with COVID-19 in ACTT-2 Trial
On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…
On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…
On Sept. 10, 2020, the NIH launched two of three adaptive Phase 3 clinical trials evaluating the safety…
On Sept. 9, 2020, the National Institutes of Health (NIH) announced that after nearly 15 years on an…
On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…
On Sept. 3, 2020, Humanigen announced the first case-control data of lenzilumab in severe COVID-19 demonstrated an 80%…
On Sept. 2, 2020, Sonic Healthcare USA was awarded a contract from the National Institutes of Health (NIH)…
On Sept. 2, 2020, Ceres Nanosciences announced it had been awarded a contract from the National Institutes of…
On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…
On Sept. 2, 2020, the NIH announced $129.3 million in scale-up and manufacturing support for a new set…
On Sept. 2, 2020, Aegis Sciences annunced that it had been selected to participate in the National Institutes…
On Sept. 2, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…
On Aug. 31, 2020, an international team of scientists supported by the National Institutes of Health (NIH) announced…
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…
On Aug. 19, 2020, the National Institutes of Health (NIH) began requiring a small nonprofit research organization to…
On Aug. 13, 2020, the NIH announced a new interactive mapping tool that showcases just some of the…
On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR)…
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
On Aug. 4, 2020, the NIH announced that patients admitted with COVID-19 at select hospitals may now volunteer…
On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…
On Jul. 31, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
On Jul. 31, 2020, the NIH announced that it had invested $248.7 million in new technologies to address…
On Jul. 27, 2020, the NIH launched a $58 million initiative to advance data science, catalyze innovation and…
On Jul. 27, 2020, Humanigen announced that the National Institute of Allergy and Infectious Diseases and Humanigen had…
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
On Jul. 22, 2020, Oragenics announced that the National Institutes of Health created stabilized pre-fusion spike protein (CoV-2…
On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…